🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well second mitochondrial-derived activator...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2014-12-18
Trial ID
NCT02098161
Treatments Being Tested
The purpose of this study was to combine the PDR001 checkpoint inhibitor wi...
Status
Completed
Location
UCLA Santa Monica Hematology / Oncology SC
Start Date
2016-10-14
Trial ID
NCT02890069
Treatments Being Tested
The study will evaluate the safety of increasing doses of oral LCL161 in pa...
Status
Completed
Location
UNC/ Lineberger Comprehensive Cancer Center Dept. of LinbergerCancerCtr(2)
Start Date
2008-11
Trial ID
NCT01098838
Treatments Being Tested
To assess whether adding LCL161 to weekly paclitaxel enhances the efficacy ...
Status
Completed
Location
Highlands Oncology Group Dept of Highlands Oncology Grp
Start Date
2012-08
Trial ID
NCT01617668
Treatments Being Tested
This trial will investigate the combination of two anti-cancer agents to tr...
Status
Terminated
Location
Florida Cancer Specialists-Sarasota
Start Date
2016-03-23
Trial ID
NCT02649673
Treatments Being Tested
This is a dose escalation study that will assess the safety and efficacy of...
Status
Completed
Location
Dana Farber Cancer Institute SC
Start Date
2011-04
Trial ID
NCT01240655
Treatments Being Tested
This study will evaluate safety and tolerability to estimate the maximum to...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-11
Trial ID
NCT01968915
Treatments Being Tested
The goal of this study is to identify the maximum tolerated dose and dose-l...
Status
Unknown
Location
2 Sites
Start Date
2014-03
Trial ID
NCT01934634
Treatments Being Tested
This phase II trial studies how well second mitochondrial-derived activator...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2013-11
Trial ID
NCT01955434
The purpose of this study is to assess the safety, tolerability, and identi...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-12-18
Trial ID
NCT03111992